Skip to content
  • Sunday, 26 July 2026
  • 1:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cerebrovascular Function and Oxygen Regulation as Early Biomarkers for Alzheimer’s Disease Risk and Cognitive Decline
Neuroscience & Brain Research

Cerebrovascular Function and Oxygen Regulation as Early Biomarkers for Alzheimer’s Disease Risk and Cognitive Decline

Rifan Muazin Mar 24, 2026 0

The intricate relationship between the brain’s vascular health and the onset of neurodegenerative conditions has reached a new milestone with…

Read More
Neuroscience & Brain Research

Rice University Researchers Develop First Comprehensive Label-Free Molecular Atlas of the Alzheimer’s Brain

Rifan Muazin Mar 24, 2026 0

In a significant leap forward for neurodegenerative research, a multidisciplinary team at Rice University has successfully generated the first comprehensive,…

Read More
Neuroscience & Brain Research

UCLA and UCSF Researchers Uncover Genetic Mechanisms Behind Neuronal Resistance to Tau Protein Buildup in Alzheimer’s Disease

Rifan Muazin Mar 23, 2026 0

The landscape of neurodegenerative research has been significantly altered by a collaborative breakthrough from scientists at UCLA Health and the…

Read More
Neuroscience & Brain Research

New Research Identifies Tanycytes as Critical Gatekeepers in the Clearance of Toxic Tau Proteins Associated with Alzheimer’s Disease

Rifan Muazin Mar 20, 2026 0

The accumulation of tau protein within the neural architecture has long been recognized as a definitive pathological hallmark of Alzheimer’s…

Read More
Neuroscience & Brain Research

Washington University Researchers Develop Single Injection Cellular Immunotherapy to Target Alzheimer’s Disease Amyloid Plaques

Rifan Muazin Mar 20, 2026 0

The landscape of neurodegenerative disease research has reached a pivotal turning point as scientists move beyond symptom management toward therapies…

Read More
Neuroscience & Brain Research

Structural Protein Profiling in Blood Offers New Frontier for Alzheimer’s Early Diagnosis and Monitoring

Rifan Muazin Mar 20, 2026 0

Alzheimer’s disease remains one of the most significant challenges to modern medicine, currently affecting an estimated 7.2 million Americans age…

Read More
Neuroscience & Brain Research

Unlocking the Mechanism of Lecanemab: VIB-KU Leuven Researchers Identify Fc Fragment as Essential for Microglial Activation in Alzheimer’s Treatment

Rifan Muazin Mar 19, 2026 0

Researchers from the VIB-KU Leuven Center for Brain & Disease Research have published a seminal study in the journal Nature…

Read More
Clinical Diagnostics & Pathology

Revolutionary Blood Test Model Forecasts Alzheimer’s Symptom Onset, Reshaping Early Detection and Clinical Trial Strategies

Reynand Amr Wu Mar 19, 2026 0

Clinical laboratories across the globe are keenly observing a pivotal shift in neurodegenerative disease diagnostics, particularly with the escalating prominence…

Read More
Neuroscience & Brain Research

Microplastics and Neurodegeneration: New Research Links Synthetic Particles to Alzheimer’s and Parkinson’s Disease Risks

Rifan Muazin Mar 14, 2026 0

The global escalation of plastic pollution has long been recognized as a primary threat to marine ecosystems and environmental stability,…

Read More

Posts pagination

1 … 8 9
Madrigal Pharmaceuticals Secures Global Rights to Arrowhead’s siRNA Asset for MASH, Paving Way for Combination Therapy ExplorationTraumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potentialMIT Researchers Unveil Breakthrough Terahertz Microscope to Observe Quantum Vibrations in Superconducting MaterialsLilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ